2021
-
The Great Debate: Enhance lupus nephritis therapy with belimumab or voclosporin?
During Saturday’s Great Debate session, Michelle Petri, MD, MPH, made the case for belimumab, while Brad Rovin, MD, argued in favor of voclosporin.
-
Plenary I: KEEPsAKE trials show risankizumab safe, effective for active psoriatic arthritis
Researchers reported results from six highly anticipated studies on Saturday during the first plenary session at ACR Convergence 2021.
-
After 70 years of groundbreaking discoveries, researchers continue to unlock mysteries of lupus
In the Philip Hench, MD Memorial Lecture on Sunday, Peggy Crow, MD, reviewed several milestones in lupus research and discussed recent discoveries that hold promise for future advances.
-
Collaboration helped Klemperer lecturer build successful career in endometriosis research
Peter Gregersen, MD, recounted his 40 years working in a changing research landscape — from RA to endometriosis — during the Paul Klemperer, MD Memorial Lecture on Saturday.
-
COVID-19 vaccines face many of the same ethical questions as other vaccines
Bioethicist Christine Grady, PhD, MSN, discussed ethical quandaries in vaccine development, rollout, and utilization, with a special focus on COVID-19 vaccines, during Saturday’s ARP keynote presentation.
-
Experts examine ethical issues in pediatric rheumatology research
Sampath Prahalad, MD, MSc, and Lainie Ross, MD, PhD, examined ethical issues surrounding genomic research and biobanking in pediatric rheumatology during a Sunday morning session.
-
Kaitlin Quinn, MD: Standardizing clinical trial recruitment in Takayasu arteritis
Kaitlin Quinn, MD, will present the poster “Using 18F-fluorodeoxyglucose Positron Emission Tomography to Standardize Clinical Trial Recruitment in Takayasu’s Arteritis” during Tuesday morninng’s Poster Session D.
-
Simón Ángel Sánchez-Fernández, PhD: SARS-CoV-2 infection in rheumatic disease patients receiving biological therapies
Simón Ángel Sánchez-Fernández, PhD, will present the poster “Evaluation of the Possible Different Evolution of SARS-CoV-2 Infection with Tumor Necrosis Factor Inhibitors or with Rituximab in Rheumatic Patients” during Tuesday morninng’s Poster Session D.
-
Ingrid Jyssum, MD: COVID-19 vaccine response in patients with inflammatory arthritis and IBD
Ingrid Jyssum, MD, will present the poster “Immune Responses to COVID-19 Vaccines in Patients Using Immunosuppressive Medication for Inflammatory Arthritis – An Observational Study of 1500 Patients” during Tuesday morninng’s Poster Session D.
-
Nicholas Sumpter, MS: Transition from hyperuricemia to gout
Nicholas Sumpter, MS, will present the poster “Genetic Effects on the Transition from Hyperuricemia to Gout” during Tuesday morninng’s Poster Session D.